knowledge -WSS

knowledge

author：focus 2025-09-03 09:19:24 - browse：1291

Blue Cross Blue Shield website seen on several laptop screens. -- health business coverage from STAT — Adobe

A program that undergirds the Affordable Care Act’s health insurance marketplaces continues to bolster the balance sheets of large Blue Cross Blue Shield companies, according to a STAT analysis of new federal data.

Conversely, that same program — called “risk adjustment” — has created substantial financial burdens for startup insurers including Bright Health Group, which has now exited all health insurance markets, and Friday Health Plans, which has shut down.

More than two dozen BCBS insurers are projected to collect more than $4.7 billion from competing insurers on the ACA marketplaces, according to the analysis. The biggest amounts are concentrated among a few dominant Blues conglomerates.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Medicare Advantage insurers face 0.2% cut to 2025 payments

WSS

STAT Boddities: What happens to the brain when we get scared?

Having children helps parents live longer, especially after age 80

Artificial intelligence use in health care faces greater scrutiny in 2024

Philips to halt sales of sleep apnea machines in U.S.

Biogen walks away from Aduhelm, years after polarizing approval

The Affordable Care Act has saved billions in health care costs

focus

knowledge

leisure time

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Long Covid research funding gets a major boost from NIH

In Memoriam: Notable people who died in 2023

Ebola vaccine can save some who are already sick, per new study

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Medicare drug price negotiation legal challenge met with skepticism

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Why don't Americans have at

As demand for Covid shots wanes, Moderna seeks its next success

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

leisure time

Congress considering partial increase for doctor pay in Medicare

Abbott's new heart device gets FDA advisory panel nod

Congress considering partial increase for doctor pay in Medicare

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Zyn nicotine pouches become unlikely player in latest culture war

leisure time

entertainment

knowledge

entertainment